Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2004-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07babeb1b35fc0fd7f6d9b07fce8764e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8906bcb129a4a4ac6bd5a1bc9e29bfa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd30164d52071795196ae5f37a1c3284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_268f68065850043a80edd110f359a81a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a1c785d29d68069495713e205836ee5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b211454c32dce379e772b5589e1e2c30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd5089cdb85f40167eec21612e6256a4 |
publicationDate |
2004-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2515585-A1 |
titleOfInvention |
Enteric sustained-release fine particles for tamsulosin or its salt and manufacturing method thereof |
abstract |
Enteric sustained-release fine particles for tamsulosin or its salt, which can be incorporated in an intraorally disintegrable tablet, and a process for producing the same. In particular, enteric sustained-release fine particles for use in intraorally disintegrable tablets, comprising (1) tamsulosin or its salt and at least (2) an enteric substance, optionally together with (3) a water insoluble substance, characterized in that: 1) the particles are those whose average diameter is in the range of about 5 to 250 µm; and 2) when with respect to intraorally disintegrable tablets containing the particles a dissolution test thereof is performed in accordance with the dissolution testing method specified in the Japanese Pharmacopoeia; a) the dissolution ratio of tamsulosin or its salt two hours after the test initiation at pH 1.2 is 25% or below; and b) the time wherein 50% of tamsulosin or its salt is dissolved at pH 6.8 is in the range of 0.5 to 5 hr; and a process for producing the same. |
priorityDate |
2003-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |